Frank Bobe

The German Life Science Accelerator is a mentoring and business development program to facilitate access to US markets and US based capital for German life science companies. A first pilot program is scheduled for October 2013.

Launched Seres Health's research and development program in June 2012 after raising a Series A round with Flagship Ventures and assembling an outstanding team of senior executives and scientists. Seres Health is pioneering a new approach to fundamentally restore and maintain healthy microbiomes. The Company was conceived of and launched by VentureLabs, Flagship Ventures' Innovation Foundry, and has recruited the world’s leaders in the scientific and clinical aspects of the human microbiome.

Launched SpringLeaf Therapeutics in November 2008 after closing the first tranche of a $12M Series A round with Flybridge Capital Partners and North Bridge Venture Partners. Assembled a worldclass interdisciplinary team of seniors executives, engineers and scientists to develop an innovative solution for subcutaneous delivery of viscous biologic therapeutics. In June 2011, a $19M Series B round was closed which was backed by the existing investors, SR One and Excel Venture Management.

Novartis - HBS Executive Forum